Seven innovative research projects have been granted funding to enhance understanding, develop better treatments, and improve care of Crohn's and Colitis.
Because of the support of people like you, for over 30 years, we have been at the forefront of groundbreaking research in Crohn's Disease and Ulcerative Colitis - with £5.2 million awarded between 2008-2017.
Due to the generosity of our partners and donors, the following projects have been granted nearly £650,000 funding from Crohn's & Colitis UK in 2018:
University of Exeter will receive £120,000 to look at Developing ways for doctors to deliver more personalised treatment.
We hope to enable safer, longer-lasting, and more cost-effective anti-TNF treatment, by developing a new way for doctors to treat patients.
Aston University & Birmingham Children’s Hospital will receive £33,790 to developing a programme to support young people (aged 13-18) with IBD to follow their treatment plans.
Through this study, we will develop a programme that equips young people with IBD with the skills, motivation and confidence they need to adhere to their recommended treatment plan now and as they transition into adulthood.
MRC Centre for Inflammation Research will receive £118,767 to investigate whether blocking ‘Danger signals’ will reduce inflammation in the bowel.
We hope our work will take us one step closer to a new treatment in IBD.
University of Cambridge will receive £87,463 to investigate genetic variations that cause IBD.
By uncovering exactly how genetic variants contribute to Crohn's Disease and Ulcerative Colitis, we aim to identify previously unknown pathways that are involved in disease development, which could provide new targets for better treatments.
Sheffield Teaching Hospitals will receive £119,967 to develop an aid to support people with Ulcerative Colitis choosing between medical and surgical treatment.
This research will help people with UC make the treatment decision that leads to an improved quality of life based on what matters most to the individual.
St George’s, University of London will receive £89,670 to look at depression and IBD. The aim of the research is to understand what influences depression in people with IBD and the effect depression can have on symptoms.
We hope that understanding how the brain and IBD interact will improve both the physical and mental wellbeing of people living with IBD.
Blizard Institute, Barts and The London School of Medicine & Dentistry will receive £73,573 to find ways to stop fibrosis in Crohn’s Disease. Researchers hope that valproic acid, or similar drugs can be used as new treatments for fibrosis in Crohn’s.
By understanding the mechanisms that drive fibrosis we will be able identify targets for future therapies.
We are passionate about the difference that research has the potential to achieve to the lives of people living with these Crohn's and Colitis, which you can read about in our report on the Power of Research.
As well as funding ground-breaking research, we connect researchers with patients, and work in partnership to advance the understanding of Crohn’s and Colitis. In the last ten years, we have invested over £5m in medical, psychological, social and health service research – directly contributing to many improvements in treatments and care for people living with these conditions.
These latest awards continue to reflect this as we want everyone living with Crohn's and Colitis to have the very best care, support and treatment available, right now. From breaking stigmas to driving up care standards across the UK, we want people to live fuller, freer and happier lives. And while we’re committed to improving the lives of everyone with Crohn's and Colitis, we’re also committed to finding a cure to end this distressing disease.
Applications for 2019 Crohn’s & Colitis UK research grants are now open. We grant three kinds of awards:
- Medical - any aspect of Inflammatory Bowel Disease relevant to a better understanding of the causes or mechanisms of IBD or better treatment for IBD patients.
- Living with IBD – any aspect of the social and psychological impact of Inflammatory Bowel Disease including research into ways of helping patients and their families to live with IBD.
- Health Services – research with the potential to improve the services provided to the UK’s IBD community and to drive up standards of care for patients with IBD.
Funding for any one project is normally subject to a maximum of £120,000 over a period of up to three years. Applications for funding of pilot studies are also encouraged.
Closing date for applications is 4pm on Monday 1 October 2018. For more information regarding these awards, please contact us at email@example.com or on 01727 734468.